Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells

Free Radical Biology and Medicine

Volumn 45, Issue 11, 2008, Pages 1573-1580

  Hitchler, Michael J ^a   Oberley, Larry W ^a   Domann, Frederick E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antioxidant; Carcinoma; Chromatin; Mammary; Methylation

Indexed keywords

BUTYRIC ACID; HISTONE; HISTONE DEACETYLASE; MANGANESE SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRICHOSTATIN A;

ACETYLATION; ARTICLE; BREAST CARCINOMA; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL;

ACETYLATION; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE SILENCING; HISTONE CODE; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; METHYLATION; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 56049116207     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.09.005     Document Type: Article

References (36)

1. Oberley L.W., Oberley T.D., and Buettner G.R. Cell division in normal and transformed cells: the possible role of superoxide and hydrogen peroxide. Med. Hypotheses 7 (1981) 21-42
2. Li J.J., Oberley L.W., St Clair D.K., Ridnour L.A., and Oberley T.D. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10 (1995) 1989-2000
3. Zhong W., Oberley L.W., Oberley T.D., and St Clair D.K. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14 (1997) 481-490
4. Ough M., Lewis A., Zhang Y., Hinkhouse M.M., Ritchie J.M., Oberley L.W., and Cullen J.J. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic. Res. 38 (2004) 1223-1233
5. Weydert C., Roling B., Liu J., Hinkhouse M.M., Ritchie J.M., Oberley L.W., and Cullen J.J. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol. Cancer Ther. 2 (2003) 361-369
6. Weydert C.J., Waugh T.A., Ritchie J.M., Iyer K.S., Smith J.L., Li L., Spitz D.R., and Oberley L.W. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic. Biol. Med. 41 (2006) 226-237
7. Bravard A., Sabatier L., Hoffschir F., Ricoul M., Luccioni C., and Dutrillaux B. SOD2: a new type of tumor-suppressor gene?. Int. J. Cancer 51 (1992) 476-480
8. Borrello S., De Leo M.E., and Galeotti T. Defective gene expression of MnSOD in cancer cells. Mol. Aspects Med. 14 (1993) 253-258
9. Lomberk G., and Urrutia R. The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem. J. 392 (2005) 1-11
10. Maehara K., Uekawa N., and Isobe K. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun. 295 (2002) 187-192
11. Zhu C.H., Huang Y., Oberley L.W., and Domann F.E. A family of AP-2 proteins down-regulate manganese superoxide dismutase expression. J. Biol. Chem. 276 (2001) 14407-14413
12. Zhu C., Huang Y., Weydert C.J., Oberley L.W., and Domann F.E. Constitutive activation of transcription factor AP-2 is associated with decreased MnSOD expression in transformed human lung fibroblasts. Antioxid. Redox Signal. 3 (2001) 387-395
13. St Clair D.K., Porntadavity S., Xu Y., and Kiningham K. Transcription regulation of human manganese superoxide dismutase gene. Methods Enzymol. 349 (2002) 306-312
14. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., Huang T.T., Bos J.L., Medema R.H., and Burgering B.M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419 (2002) 316-321
15. St Clair D.K., and Holland J.C. Complementary DNA encoding human colon cancer manganese superoxide dismutase and the expression of its gene in human cells. Cancer Res. 51 (1991) 939-943
16. Hodge D.R., Xiao W., Peng B., Cherry J.C., Munroe D.J., and Farrar W.L. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. Cancer Res. 65 (2005) 6255-6263
17. Hurt E.M., Thomas S.B., Peng B., and Farrar W.L. Integrated molecular profiling of SOD2 expression in multiple myeloma. Blood 109 (2007) 3953-3962
18. Hurt E.M., Thomas S.B., Peng B., and Farrar W.L. Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines. Br. J. Cancer 97 (2007) 1116-1123
19. Huang Y., Peng J., Oberley L.W., and Domann F.E. Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5′ CpG island. Free Radic. Biol. Med. 23 (1997) 314-320
20. Hitchler M.J., Wikainapakul K., Yu L., Powers K., Attatippaholkun W., and Domann F.E. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells. Epigenetics 1 (2006) 163-171
21. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
22. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
23. Musri M.M., Corominola H., Casamitjana R., Gomis R., and Parrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J. Biol. Chem. 281 (2006) 17180-17188
24. Ranjan P., and Boss J.M. C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis. Apoptosis 11 (2006) 1837-1849
25. Beauchamp C., and Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44 (1971) 276-287
26. Rose S.L., Fitzgerald M.P., White N.O., Hitchler M.J., Futscher B.W., De Geest K., and Domann F.E. Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol. Oncol. 102 (2006) 319-324
27. Xu Y., Krishnan A., Wan X.S., Majima H., Yeh C.C., Ludewig G., Kasarskis E.J., and St Clair D.K. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 18 (1999) 93-102
28. Huang Y., He T., and Domann F.E. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol. 18 (1999) 643-652
29. Hodge D.R., Peng B., Pompeia C., Thomas S., Cho E., Clausen P.A., Marquez V.E., and Farrar W.L. Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol. Ther. 4 (2005) 585-592
30. Fuks F., Hurd P.J., Deplus R., and Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31 (2003) 2305-2312
31. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., and Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278 (2003) 4035-4040
32. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K., Iyer N.G., Perez-Rosado A., Calvo E., Lopez J.A., Cano A., Calasanz M.J., Colomer D., Piris M.A., Ahn N., Imhof A., Caldas C., Jenuwein T., and Esteller M. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37 (2005) 391-400
33. Guo Z., Boekhoudt G.H., and Boss J.M. Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous superoxide dismutase. J. Biol. Chem. 278 (2003) 23570-23578
34. Taddei A., Roche D., Bickmore W.A., and Almouzni G. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?. EMBO Rep. 6 (2005) 520-524
35. Malafa M., Margenthaler J., Webb B., Neitzel L., and Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J. Surg. Res. 88 (2000) 130-134
36. Lewis A., Du J., Liu J., Ritchie J.M., Oberley L.W., and Cullen J.J. Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth. Clin. Exp. Metastasis 22 (2005) 523-532